Cargando…
Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers
Autores principales: | Liang, Lilian Yan, Wong, Vincent Wai-Sun, Wong, Grace Lai-Hung, Yip, Terry Cheuk-Fung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845680/ https://www.ncbi.nlm.nih.gov/pubmed/36314042 http://dx.doi.org/10.3350/cmh.2022.0333 |
Ejemplares similares
-
Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
por: Yip, Terry Cheuk-Fung, et al.
Publicado: (2021) -
Alanine Aminotransferase Level: The Road to Normal in 2021
por: Yip, Terry Cheuk‐Fung, et al.
Publicado: (2021) -
Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir
por: Wong, Grace Lai-Hung, et al.
Publicado: (2022) -
Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B
por: Liang, Lilian Yan, et al.
Publicado: (2021) -
Secondary prevention for hepatocellular carcinoma in patients with chronic hepatitis B: are all the nucleos(t)ide analogues the same?
por: Yip, Terry Cheuk-Fung, et al.
Publicado: (2020)